
|Articles|January 28, 2015
Segment 6: Learning About CancerLinQ as It Rolls Out
Daniel Hayes, MD, explains the implementation of the American Society of Clinical Oncology's CancerLinQ for beta testing.
Advertisement
Moderator Surabhi Dangi-Garimella asked Daniel Hayes, MD, who has been elected president of the American Society of Clinical Oncology (ASCO) for the term beginning in June 2016, what changes practices would have to adopt to implement ASCO’s CancerLinQ.
Currently, ASCO is rolling out CancerLinQ for beta testing in a number of practices, but he admits they don’t really know how it will function until they put it to work.
“I think as it becomes increasingly more successful, other practices will see the advantages of being enrolled,” he said.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Prior Cancer History Predicts Second Cancers in Polycythemia Vera, Essential Thrombocythemia
2
Medicaid MFN Pricing Could Save $8.6 Billion
3
CRC Treatment Delays Linked to Higher Metastasis Risk, Supporting Pathway-Specific Benchmarks
4
Active US Drug Shortages Rise for Third Straight Quarter
5




